Panacea Biotec Limited (PANACEABIO.NS)

INR 544.6

(-1.37%)

Revenue Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual revenue in 2023 was 5.59 Billion INR , up 21.57% from previous year.
Panacea Biotec Limited's latest quarterly revenue in 2024 Q1 was 1.15 Billion INR , down -15.2% from previous quarter.
Panacea Biotec Limited reported a annual revenue of 4.59 Billion INR in annual revenue 2022, down -30.23% from previous year.
Panacea Biotec Limited reported a annual revenue of 6.59 Billion INR in annual revenue 2021, up 6.73% from previous year.
Panacea Biotec Limited reported a quarterly revenue of 5.59 Billion INR for 2023 FY, up 21.57% from previous quarter.
Panacea Biotec Limited reported a quarterly revenue of 1.29 Billion INR for 2023 Q1, up 0.2% from previous quarter.

Annual Revenue Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Revenue of Panacea Biotec Limited (2023 - 2004)

Year	Revenue	Revenue Growth
2023	5.59 Billion INR	21.57%
2022	4.59 Billion INR	-30.23%
2021	6.59 Billion INR	6.73%
2020	6.17 Billion INR	14.98%
2019	5.37 Billion INR	18.76%
2018	4.52 Billion INR	-22.81%
2017	5.86 Billion INR	7.57%
2016	5.44 Billion INR	-16.58%
2015	6.53 Billion INR	-4.96%
2014	6.87 Billion INR	33.34%
2013	5.15 Billion INR	-15.3%
2012	6.08 Billion INR	-14.31%
2011	7.1 Billion INR	-37.92%
2010	11.43 Billion INR	27.07%
2009	9 Billion INR	14.21%
2008	7.88 Billion INR	-6.32%
2007	8.41 Billion INR	-0.12%
2006	8.42 Billion INR	55.44%
2005	5.41 Billion INR	65.25%
2004	3.27 Billion INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	1.15 Billion INR	-15.2%
2023 FY	5.59 Billion INR	21.57%
2023 Q1	1.29 Billion INR	0.2%
2023 Q2	1.43 Billion INR	10.71%
2023 Q3	1.5 Billion INR	5.23%
2023 Q4	1.36 Billion INR	-9.33%
2022 Q2	1.05 Billion INR	-5.04%
2022 Q4	1.28 Billion INR	11.92%
2022 FY	4.59 Billion INR	-30.23%
2022 Q1	1.1 Billion INR	-20.2%
2022 Q3	1.15 Billion INR	9.59%
2021 Q4	1.38 Billion INR	-11.01%
2021 FY	6.59 Billion INR	6.73%
2021 Q3	1.55 Billion INR	-32.86%
2021 Q1	1.32 Billion INR	-17.79%
2021 Q2	2.32 Billion INR	75.29%
2020 FY	6.17 Billion INR	14.98%
2020 Q4	1.61 Billion INR	13.65%
2020 Q3	1.41 Billion INR	-22.12%
2020 Q2	1.82 Billion INR	37.1%
2020 Q1	1.32 Billion INR	12.05%
2019 Q2	1.25 Billion INR	-0.48%
2019 Q3	1.67 Billion INR	34.0%
2019 Q4	1.18 Billion INR	-29.36%
2019 FY	5.37 Billion INR	18.76%
2019 Q1	1.25 Billion INR	2.81%
2018 Q4	1.22 Billion INR	10.84%
2018 Q2	1.2 Billion INR	21.2%
2018 Q1	992.8 Million INR	0.0%
2018 FY	4.52 Billion INR	-22.81%
2018 Q3	1.1 Billion INR	-8.27%
2017 FY	5.86 Billion INR	7.57%
2016 FY	5.44 Billion INR	-16.58%
2015 FY	6.53 Billion INR	-4.96%
2014 FY	6.87 Billion INR	33.34%
2013 FY	5.15 Billion INR	-15.3%
2012 FY	6.08 Billion INR	-14.31%
2011 FY	7.1 Billion INR	-37.92%
2010 FY	11.43 Billion INR	27.07%
2009 FY	9 Billion INR	14.21%
2008 FY	7.88 Billion INR	-6.32%
2007 FY	8.41 Billion INR	-0.12%
2006 FY	8.42 Billion INR	55.44%
2005 FY	5.41 Billion INR	65.25%
2004 FY	3.27 Billion INR	0.0%

Peer Revenue Comparison of Panacea Biotec Limited

Name	Revenue	Revenue Difference
Biocon Limited	147.55 Billion INR	96.21%
Blue Jet Healthcare Limited	7.11 Billion INR	21.421%
Concord Biotech Limited	9.98 Billion INR	43.974%
Dishman Carbogen Amcis Limited	26.15 Billion INR	78.623%
Jubilant Ingrevia Limited	41 Billion INR	86.363%
Lyka Labs Limited	1.05 Billion INR	-431.873%
Piramal Pharma Limited	81.71 Billion INR	93.157%
SMS Lifesciences India Limited	3.05 Billion INR	-82.76%
Supriya Lifescience Limited	5.7 Billion INR	1.964%
Syngene International Limited	34.88 Billion INR	83.972%
TAKE Solutions Limited	656.08 Million INR	-752.289%
Zota Health Care Limited	1.8 Billion INR	-209.809%